260 related articles for article (PubMed ID: 18976637)
1. Some commonly used caspase substrates and inhibitors lack the specificity required to monitor individual caspase activity.
Pereira NA; Song Z
Biochem Biophys Res Commun; 2008 Dec; 377(3):873-7. PubMed ID: 18976637
[TBL] [Abstract][Full Text] [Related]
2. Overlapping cleavage motif selectivity of caspases: implications for analysis of apoptotic pathways.
McStay GP; Salvesen GS; Green DR
Cell Death Differ; 2008 Feb; 15(2):322-31. PubMed ID: 17975551
[TBL] [Abstract][Full Text] [Related]
3. Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases.
Bajusz S; Fauszt I; Németh K; Barabás E; Juhász A; Patthy M; Bauer PI
Biopolymers; 1999; 51(1):109-18. PubMed ID: 10380358
[TBL] [Abstract][Full Text] [Related]
4. Identification of early intermediates of caspase activation using selective inhibitors and activity-based probes.
Berger AB; Witte MD; Denault JB; Sadaghiani AM; Sexton KM; Salvesen GS; Bogyo M
Mol Cell; 2006 Aug; 23(4):509-21. PubMed ID: 16916639
[TBL] [Abstract][Full Text] [Related]
5. Caspase-8 specificity probed at subsite S(4): crystal structure of the caspase-8-Z-DEVD-cho complex.
Blanchard H; Donepudi M; Tschopp M; Kodandapani L; Wu JC; Grütter MG
J Mol Biol; 2000 Sep; 302(1):9-16. PubMed ID: 10964557
[TBL] [Abstract][Full Text] [Related]
6. Life-giving caspases: revealing new roles during mouse embryo preimplantation development.
Busso D; Dominguez C; Perez-Acle T; Moreno RD
Int J Dev Biol; 2010; 54(5):857-65. PubMed ID: 20336607
[TBL] [Abstract][Full Text] [Related]
7. N-Ac-DEVD-N'-(Polyfluorobenzoyl)-R110: novel cell-permeable fluorogenic caspase substrates for the detection of caspase activity and apoptosis.
Zhang HZ; Kasibhatla S; Guastella J; Tseng B; Drewe J; Cai SX
Bioconjug Chem; 2003; 14(2):458-63. PubMed ID: 12643757
[TBL] [Abstract][Full Text] [Related]
8. Caspase inhibitors: viral, cellular and chemical.
Callus BA; Vaux DL
Cell Death Differ; 2007 Jan; 14(1):73-8. PubMed ID: 16946729
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, enzymatic evaluation, and docking studies of fluorogenic caspase 8 tetrapeptide substrates.
Reszka P; Schulz R; Methling K; Lalk M; Bednarski PJ
ChemMedChem; 2010 Jan; 5(1):103-17. PubMed ID: 19918833
[TBL] [Abstract][Full Text] [Related]
10. Malonate-assisted purification of human caspases.
Scheer JM; Wells JA; Romanowski MJ
Protein Expr Purif; 2005 May; 41(1):148-53. PubMed ID: 15802232
[TBL] [Abstract][Full Text] [Related]
11. Structural and kinetic analysis of caspase-3 reveals role for s5 binding site in substrate recognition.
Fang B; Boross PI; Tozser J; Weber IT
J Mol Biol; 2006 Jul; 360(3):654-66. PubMed ID: 16781734
[TBL] [Abstract][Full Text] [Related]
12. Transient protective effect of caspase inhibitors in RCS rat.
Perche O; Doly M; Ranchon-Cole I
Exp Eye Res; 2008 Mar; 86(3):519-27. PubMed ID: 18272151
[TBL] [Abstract][Full Text] [Related]
13. Correlating the fractional inhibition of caspase-3 in NT2 cells with apoptotic markers using an active-caspase-3 enzyme-linked immunosorbent assay.
Tawa P; Giroux A; Grimm E; Han Y; Nicholson DW; Xanthoudakis S
Anal Biochem; 2006 Mar; 350(1):32-40. PubMed ID: 16430849
[TBL] [Abstract][Full Text] [Related]
14. Structural and functional definition of the specificity of a novel caspase-3 inhibitor, Ac-DNLD-CHO.
Yoshimori A; Sakai J; Sunaga S; Kobayashi T; Takahashi S; Okita N; Takasawa R; Tanuma S
BMC Pharmacol; 2007 Jun; 7():8. PubMed ID: 17594508
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of papain-like cysteine proteases and legumain by caspase-specific inhibitors: when reaction mechanism is more important than specificity.
Rozman-Pungercar J; Kopitar-Jerala N; Bogyo M; Turk D; Vasiljeva O; Stefe I; Vandenabeele P; Brömme D; Puizdar V; Fonović M; Trstenjak-Prebanda M; Dolenc I; Turk V; Turk B
Cell Death Differ; 2003 Aug; 10(8):881-8. PubMed ID: 12867995
[TBL] [Abstract][Full Text] [Related]
16. Serine protease inhibitors N-alpha-tosyl-L-lysinyl-chloromethylketone (TLCK) and N-tosyl-L-phenylalaninyl-chloromethylketone (TPCK) are potent inhibitors of activated caspase proteases.
Frydrych I; Mlejnek P
J Cell Biochem; 2008 Apr; 103(5):1646-56. PubMed ID: 17879947
[TBL] [Abstract][Full Text] [Related]
17. Caspase assays: identifying caspase activity and substrates in vitro and in vivo.
Pop C; Salvesen GS; Scott FL
Methods Enzymol; 2008; 446():351-67. PubMed ID: 18603133
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of recombinant caspase specificity by competitive substrates.
Benkova B; Lozanov V; Ivanov IP; Mitev V
Anal Biochem; 2009 Nov; 394(1):68-74. PubMed ID: 19595985
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and evaluation of aza-peptide Michael acceptors as selective and potent inhibitors of caspases-2, -3, -6, -7, -8, -9, and -10.
Ekici OD; Li ZZ; Campbell AJ; James KE; Asgian JL; Mikolajczyk J; Salvesen GS; Ganesan R; Jelakovic S; Grütter MG; Powers JC
J Med Chem; 2006 Sep; 49(19):5728-49. PubMed ID: 16970398
[TBL] [Abstract][Full Text] [Related]
20. Plasticity of S2-S4 specificity pockets of executioner caspase-7 revealed by structural and kinetic analysis.
Agniswamy J; Fang B; Weber IT
FEBS J; 2007 Sep; 274(18):4752-65. PubMed ID: 17697120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
